Recruiting Rheumatoid Arthritis Studies in Fort Worth
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD...
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medul...
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SCN1A-positive Dravet syndrome aged ≥6 to \<36 months (Part 1) and aged ≥6 to \<48...
About Rheumatoid Arthritis Clinical Trials in Fort Worth
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.
There are currently 3 rheumatoid arthritis clinical trials recruiting participants in Fort Worth, TEXAS. These studies are seeking a combined 352 participants. Research is being sponsored by Immunovant Sciences GmbH, St. Jude Children's Research Hospital, Encoded Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rheumatoid Arthritis Clinical Trials in Fort Worth — FAQ
Are there rheumatoid arthritis clinical trials in Fort Worth?
Yes, there are 3 rheumatoid arthritis clinical trials currently recruiting in Fort Worth, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fort Worth?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Worth research site will contact you about next steps.
Are clinical trials in Fort Worth free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Worth studies also compensate for your time and travel.
What rheumatoid arthritis treatments are being tested?
The 3 active trials in Fort Worth are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov